Similar articles

• [Catecholamine-induced cardiomyopathy triggered by pheochromocytoma].

  Navarro I, Molina M, Civera M, Ascaso JF, Real JT, Carmena R. Navarro I, et al. Endocrinol Nutr. 2011 Apr;58(4):204-6. doi: 10.1016/j.endonu.2010.11.005. Epub 2011 Mar 9. Endocrinol Nutr. 2011. PMID: 21393076 Review. Spanish. No abstract available.
• [Diagnosis of secreting pheochromocytoma].

  Bovy P, Juchmès J, Bourdon V, Smeets JP, Cession-Fossion A, Godon JP, Siquet R, Rahman M, Rorive G, Lecomte J. Bovy P, et al. Rev Med Liege. 1980 Nov 1;35(21):724-9. Rev Med Liege. 1980. PMID: 7455452 French. No abstract available.
• [Patients undergoing adrenalectomy for phaeochromocytoma must not receive consistently hypotensive drugs or volume loading].

  Lentschener C, Gaujoux S. Lentschener C, et al. Ann Fr Anesth Reanim. 2010 Jan;29(1):60-1; author reply 61-2. doi: 10.1016/j.annfar.2009.12.010. Epub 2010 Jan 15. Ann Fr Anesth Reanim. 2010. PMID: 20080015 French. No abstract available.
• [Neurofibromatosis type I and hypertension: a case report].

  Rocchietti March M, De Palma C, L'Angiocola PD, Aliberti G. Rocchietti March M, et al. Recenti Prog Med. 2008 Dec;99(12):602-5. Recenti Prog Med. 2008. PMID: 19388218 Italian.
• Modern management of pheochromocytoma.

  Kasturi S, Kutikov A, Guzzo TJ, Smith AL, Wein AJ. Kasturi S, et al. Nat Clin Pract Urol. 2007 Nov;4(11):630-3. doi: 10.1038/ncpuro0962. Nat Clin Pract Urol. 2007. PMID: 17982440 Review.